安定同位体標識化合物のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Stable Isotopically Labeled Compounds Market Insights, Forecast to 2028

• レポートコード：QY2207E02531 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の安定同位体標識化合物の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に安定同位体標識化合物の世界市場のxxx％を占める「水-18O」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の安定同位体標識化合物の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの安定同位体標識化合物市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの安定同位体標識化合物市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 安定同位体標識化合物のグローバル主要メーカーには、Rotem Industries Israel、Huayi Isotopes、ABX、CIL、Wosotop、Tayio Nippon Sanso、CMR、Cambridge Isotope Laboratories、Merck KGaA、Urenco Limited、Isosciences、Medical Isotopes、Omicron Biochemicals、BWX Technologies、Trace Sciences International、Alsachim、Perkinelmerなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 安定同位体標識化合物市場は、種類と用途によって区分されます。世界の安定同位体標識化合物市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 水-18O、酸素-18O、13C標識化合物、18F標識化合物、11C標識化合物、D標識化合物、2H標識化合物、15N標識化合物、その他 【用途別セグメント】 科学研究、臨床診断、工業、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 安定同位体標識化合物製品概要 - 種類別市場（水-18O、酸素-18O、13C標識化合物、18F標識化合物、11C標識化合物、D標識化合物、2H標識化合物、15N標識化合物、その他） - 用途別市場（科学研究、臨床診断、工業、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の安定同位体標識化合物販売量予測2017-2028 - 世界の安定同位体標識化合物売上予測2017-2028 - 安定同位体標識化合物の地域別販売量 - 安定同位体標識化合物の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別安定同位体標識化合物販売量 - 主要メーカー別安定同位体標識化合物売上 - 主要メーカー別安定同位体標識化合物価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（水-18O、酸素-18O、13C標識化合物、18F標識化合物、11C標識化合物、D標識化合物、2H標識化合物、15N標識化合物、その他） - 安定同位体標識化合物の種類別販売量 - 安定同位体標識化合物の種類別売上 - 安定同位体標識化合物の種類別価格 ・用途別市場規模（科学研究、臨床診断、工業、その他） - 安定同位体標識化合物の用途別販売量 - 安定同位体標識化合物の用途別売上 - 安定同位体標識化合物の用途別価格 ・北米市場 - 北米の安定同位体標識化合物市場規模（種類別、用途別） - 主要国別の安定同位体標識化合物市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの安定同位体標識化合物市場規模（種類別、用途別） - 主要国別の安定同位体標識化合物市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の安定同位体標識化合物市場規模（種類別、用途別） - 主要国別の安定同位体標識化合物市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の安定同位体標識化合物市場規模（種類別、用途別） - 主要国別の安定同位体標識化合物市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの安定同位体標識化合物市場規模（種類別、用途別） - 主要国別の安定同位体標識化合物市場規模（トルコ、サウジアラビア） ・企業情報 Rotem Industries Israel、Huayi Isotopes、ABX、CIL、Wosotop、Tayio Nippon Sanso、CMR、Cambridge Isotope Laboratories、Merck KGaA、Urenco Limited、Isosciences、Medical Isotopes、Omicron Biochemicals、BWX Technologies、Trace Sciences International、Alsachim、Perkinelmer ・産業チェーン及び販売チャネル分析 - 安定同位体標識化合物の産業チェーン分析 - 安定同位体標識化合物の原材料 - 安定同位体標識化合物の生産プロセス - 安定同位体標識化合物の販売及びマーケティング - 安定同位体標識化合物の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 安定同位体標識化合物の産業動向 - 安定同位体標識化合物のマーケットドライバー - 安定同位体標識化合物の課題 - 安定同位体標識化合物の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Stable Isotopically Labeled Compounds Market
Due to the COVID-19 pandemic, the global Stable Isotopically Labeled Compounds market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Water-18O accounting for % of the Stable Isotopically Labeled Compounds global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Stable Isotopically Labeled Compounds market size is valued at US$ million in 2021, while the US and Europe Stable Isotopically Labeled Compounds are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Stable Isotopically Labeled Compounds landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Stable Isotopically Labeled Compounds include Rotem Industries Israel, Huayi Isotopes, ABX, CIL, Wosotop, Tayio Nippon Sanso, CMR, Cambridge Isotope Laboratories and Merck KGaA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Stable Isotopically Labeled Compounds capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Stable Isotopically Labeled Compounds by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Stable Isotopically Labeled Compounds Scope and Segment
Stable Isotopically Labeled Compounds market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Stable Isotopically Labeled Compounds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Water-18O
Oxygen-18O
13C Labelled Compounds
18F Labelled Compounds
11C Labelled Compounds
D Labelled Compounds
2H Labelled Compounds
15N Labelled Compounds
Others
Segment by Application
Scientific Research
Clinical Diagnostics
Industrial
Others
By Company
Rotem Industries Israel
Huayi Isotopes
ABX
CIL
Wosotop
Tayio Nippon Sanso
CMR
Cambridge Isotope Laboratories
Merck KGaA
Urenco Limited
Isosciences
Medical Isotopes
Omicron Biochemicals
BWX Technologies
Trace Sciences International
Alsachim
Perkinelmer
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Stable Isotopically Labeled Compounds Product Introduction
1.2 Market by Type
1.2.1 Global Stable Isotopically Labeled Compounds Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Water-18O
1.2.3 Oxygen-18O
1.2.4 13C Labelled Compounds
1.2.5 18F Labelled Compounds
1.2.6 11C Labelled Compounds
1.2.7 D Labelled Compounds
1.2.8 2H Labelled Compounds
1.2.9 15N Labelled Compounds
1.2.10 Others
1.3 Market by Application
1.3.1 Global Stable Isotopically Labeled Compounds Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Clinical Diagnostics
1.3.4 Industrial
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Stable Isotopically Labeled Compounds Production
2.1 Global Stable Isotopically Labeled Compounds Production Capacity (2017-2028)
2.2 Global Stable Isotopically Labeled Compounds Production by Region: 2017 VS 2021 VS 2028
2.3 Global Stable Isotopically Labeled Compounds Production by Region
2.3.1 Global Stable Isotopically Labeled Compounds Historic Production by Region (2017-2022)
2.3.2 Global Stable Isotopically Labeled Compounds Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Stable Isotopically Labeled Compounds Sales in Volume & Value Estimates and Forecasts
3.1 Global Stable Isotopically Labeled Compounds Sales Estimates and Forecasts 2017-2028
3.2 Global Stable Isotopically Labeled Compounds Revenue Estimates and Forecasts 2017-2028
3.3 Global Stable Isotopically Labeled Compounds Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Stable Isotopically Labeled Compounds Sales by Region
3.4.1 Global Stable Isotopically Labeled Compounds Sales by Region (2017-2022)
3.4.2 Global Sales Stable Isotopically Labeled Compounds by Region (2023-2028)
3.5 Global Stable Isotopically Labeled Compounds Revenue by Region
3.5.1 Global Stable Isotopically Labeled Compounds Revenue by Region (2017-2022)
3.5.2 Global Stable Isotopically Labeled Compounds Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Stable Isotopically Labeled Compounds Production Capacity by Manufacturers
4.2 Global Stable Isotopically Labeled Compounds Sales by Manufacturers
4.2.1 Global Stable Isotopically Labeled Compounds Sales by Manufacturers (2017-2022)
4.2.2 Global Stable Isotopically Labeled Compounds Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Stable Isotopically Labeled Compounds in 2021
4.3 Global Stable Isotopically Labeled Compounds Revenue by Manufacturers
4.3.1 Global Stable Isotopically Labeled Compounds Revenue by Manufacturers (2017-2022)
4.3.2 Global Stable Isotopically Labeled Compounds Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Stable Isotopically Labeled Compounds Revenue in 2021
4.4 Global Stable Isotopically Labeled Compounds Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Stable Isotopically Labeled Compounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Stable Isotopically Labeled Compounds Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Stable Isotopically Labeled Compounds Sales by Type
5.1.1 Global Stable Isotopically Labeled Compounds Historical Sales by Type (2017-2022)
5.1.2 Global Stable Isotopically Labeled Compounds Forecasted Sales by Type (2023-2028)
5.1.3 Global Stable Isotopically Labeled Compounds Sales Market Share by Type (2017-2028)
5.2 Global Stable Isotopically Labeled Compounds Revenue by Type
5.2.1 Global Stable Isotopically Labeled Compounds Historical Revenue by Type (2017-2022)
5.2.2 Global Stable Isotopically Labeled Compounds Forecasted Revenue by Type (2023-2028)
5.2.3 Global Stable Isotopically Labeled Compounds Revenue Market Share by Type (2017-2028)
5.3 Global Stable Isotopically Labeled Compounds Price by Type
5.3.1 Global Stable Isotopically Labeled Compounds Price by Type (2017-2022)
5.3.2 Global Stable Isotopically Labeled Compounds Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Stable Isotopically Labeled Compounds Sales by Application
6.1.1 Global Stable Isotopically Labeled Compounds Historical Sales by Application (2017-2022)
6.1.2 Global Stable Isotopically Labeled Compounds Forecasted Sales by Application (2023-2028)
6.1.3 Global Stable Isotopically Labeled Compounds Sales Market Share by Application (2017-2028)
6.2 Global Stable Isotopically Labeled Compounds Revenue by Application
6.2.1 Global Stable Isotopically Labeled Compounds Historical Revenue by Application (2017-2022)
6.2.2 Global Stable Isotopically Labeled Compounds Forecasted Revenue by Application (2023-2028)
6.2.3 Global Stable Isotopically Labeled Compounds Revenue Market Share by Application (2017-2028)
6.3 Global Stable Isotopically Labeled Compounds Price by Application
6.3.1 Global Stable Isotopically Labeled Compounds Price by Application (2017-2022)
6.3.2 Global Stable Isotopically Labeled Compounds Price Forecast by Application (2023-2028)
7 North America
7.1 North America Stable Isotopically Labeled Compounds Market Size by Type
7.1.1 North America Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
7.1.2 North America Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
7.2 North America Stable Isotopically Labeled Compounds Market Size by Application
7.2.1 North America Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
7.2.2 North America Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
7.3 North America Stable Isotopically Labeled Compounds Sales by Country
7.3.1 North America Stable Isotopically Labeled Compounds Sales by Country (2017-2028)
7.3.2 North America Stable Isotopically Labeled Compounds Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Stable Isotopically Labeled Compounds Market Size by Type
8.1.1 Europe Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
8.1.2 Europe Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
8.2 Europe Stable Isotopically Labeled Compounds Market Size by Application
8.2.1 Europe Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
8.2.2 Europe Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
8.3 Europe Stable Isotopically Labeled Compounds Sales by Country
8.3.1 Europe Stable Isotopically Labeled Compounds Sales by Country (2017-2028)
8.3.2 Europe Stable Isotopically Labeled Compounds Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Stable Isotopically Labeled Compounds Market Size by Type
9.1.1 Asia Pacific Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
9.1.2 Asia Pacific Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
9.2 Asia Pacific Stable Isotopically Labeled Compounds Market Size by Application
9.2.1 Asia Pacific Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
9.2.2 Asia Pacific Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
9.3 Asia Pacific Stable Isotopically Labeled Compounds Sales by Region
9.3.1 Asia Pacific Stable Isotopically Labeled Compounds Sales by Region (2017-2028)
9.3.2 Asia Pacific Stable Isotopically Labeled Compounds Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Stable Isotopically Labeled Compounds Market Size by Type
10.1.1 Latin America Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
10.1.2 Latin America Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
10.2 Latin America Stable Isotopically Labeled Compounds Market Size by Application
10.2.1 Latin America Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
10.2.2 Latin America Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
10.3 Latin America Stable Isotopically Labeled Compounds Sales by Country
10.3.1 Latin America Stable Isotopically Labeled Compounds Sales by Country (2017-2028)
10.3.2 Latin America Stable Isotopically Labeled Compounds Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Stable Isotopically Labeled Compounds Market Size by Type
11.1.1 Middle East and Africa Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
11.1.2 Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
11.2 Middle East and Africa Stable Isotopically Labeled Compounds Market Size by Application
11.2.1 Middle East and Africa Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
11.2.2 Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
11.3 Middle East and Africa Stable Isotopically Labeled Compounds Sales by Country
11.3.1 Middle East and Africa Stable Isotopically Labeled Compounds Sales by Country (2017-2028)
11.3.2 Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Rotem Industries Israel
12.1.1 Rotem Industries Israel Corporation Information
12.1.2 Rotem Industries Israel Overview
12.1.3 Rotem Industries Israel Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Rotem Industries Israel Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Rotem Industries Israel Recent Developments
12.2 Huayi Isotopes
12.2.1 Huayi Isotopes Corporation Information
12.2.2 Huayi Isotopes Overview
12.2.3 Huayi Isotopes Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Huayi Isotopes Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Huayi Isotopes Recent Developments
12.3 ABX
12.3.1 ABX Corporation Information
12.3.2 ABX Overview
12.3.3 ABX Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 ABX Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 ABX Recent Developments
12.4 CIL
12.4.1 CIL Corporation Information
12.4.2 CIL Overview
12.4.3 CIL Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 CIL Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 CIL Recent Developments
12.5 Wosotop
12.5.1 Wosotop Corporation Information
12.5.2 Wosotop Overview
12.5.3 Wosotop Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Wosotop Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Wosotop Recent Developments
12.6 Tayio Nippon Sanso
12.6.1 Tayio Nippon Sanso Corporation Information
12.6.2 Tayio Nippon Sanso Overview
12.6.3 Tayio Nippon Sanso Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Tayio Nippon Sanso Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Tayio Nippon Sanso Recent Developments
12.7 CMR
12.7.1 CMR Corporation Information
12.7.2 CMR Overview
12.7.3 CMR Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 CMR Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 CMR Recent Developments
12.8 Cambridge Isotope Laboratories
12.8.1 Cambridge Isotope Laboratories Corporation Information
12.8.2 Cambridge Isotope Laboratories Overview
12.8.3 Cambridge Isotope Laboratories Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Cambridge Isotope Laboratories Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Cambridge Isotope Laboratories Recent Developments
12.9 Merck KGaA
12.9.1 Merck KGaA Corporation Information
12.9.2 Merck KGaA Overview
12.9.3 Merck KGaA Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Merck KGaA Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Merck KGaA Recent Developments
12.10 Urenco Limited
12.10.1 Urenco Limited Corporation Information
12.10.2 Urenco Limited Overview
12.10.3 Urenco Limited Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Urenco Limited Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Urenco Limited Recent Developments
12.11 Isosciences
12.11.1 Isosciences Corporation Information
12.11.2 Isosciences Overview
12.11.3 Isosciences Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Isosciences Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Isosciences Recent Developments
12.12 Medical Isotopes
12.12.1 Medical Isotopes Corporation Information
12.12.2 Medical Isotopes Overview
12.12.3 Medical Isotopes Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Medical Isotopes Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Medical Isotopes Recent Developments
12.13 Omicron Biochemicals
12.13.1 Omicron Biochemicals Corporation Information
12.13.2 Omicron Biochemicals Overview
12.13.3 Omicron Biochemicals Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Omicron Biochemicals Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Omicron Biochemicals Recent Developments
12.14 BWX Technologies
12.14.1 BWX Technologies Corporation Information
12.14.2 BWX Technologies Overview
12.14.3 BWX Technologies Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 BWX Technologies Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 BWX Technologies Recent Developments
12.15 Trace Sciences International
12.15.1 Trace Sciences International Corporation Information
12.15.2 Trace Sciences International Overview
12.15.3 Trace Sciences International Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Trace Sciences International Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Trace Sciences International Recent Developments
12.16 Alsachim
12.16.1 Alsachim Corporation Information
12.16.2 Alsachim Overview
12.16.3 Alsachim Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Alsachim Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Alsachim Recent Developments
12.17 Perkinelmer
12.17.1 Perkinelmer Corporation Information
12.17.2 Perkinelmer Overview
12.17.3 Perkinelmer Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Perkinelmer Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Perkinelmer Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Stable Isotopically Labeled Compounds Industry Chain Analysis
13.2 Stable Isotopically Labeled Compounds Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Stable Isotopically Labeled Compounds Production Mode & Process
13.4 Stable Isotopically Labeled Compounds Sales and Marketing
13.4.1 Stable Isotopically Labeled Compounds Sales Channels
13.4.2 Stable Isotopically Labeled Compounds Distributors
13.5 Stable Isotopically Labeled Compounds Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Stable Isotopically Labeled Compounds Industry Trends
14.2 Stable Isotopically Labeled Compounds Market Drivers
14.3 Stable Isotopically Labeled Compounds Market Challenges
14.4 Stable Isotopically Labeled Compounds Market Restraints
15 Key Finding in The Global Stable Isotopically Labeled Compounds Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Stable Isotopically Labeled Compounds Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Water-18O
Table 3. Major Manufacturers of Oxygen-18O
Table 4. Major Manufacturers of 13C Labelled Compounds
Table 5. Major Manufacturers of 18F Labelled Compounds
Table 6. Major Manufacturers of 11C Labelled Compounds
Table 7. Major Manufacturers of D Labelled Compounds
Table 8. Major Manufacturers of 2H Labelled Compounds
Table 9. Major Manufacturers of 15N Labelled Compounds
Table 10. Major Manufacturers of Others
Table 11. Global Stable Isotopically Labeled Compounds Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 12. Global Stable Isotopically Labeled Compounds Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 13. Global Stable Isotopically Labeled Compounds Production by Region (2017-2022) & (Tons)
Table 14. Global Stable Isotopically Labeled Compounds Production Market Share by Region (2017-2022)
Table 15. Global Stable Isotopically Labeled Compounds Production by Region (2023-2028) & (Tons)
Table 16. Global Stable Isotopically Labeled Compounds Production Market Share by Region (2023-2028)
Table 17. Global Stable Isotopically Labeled Compounds Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 18. Global Stable Isotopically Labeled Compounds Sales by Region (2017-2022) & (Tons)
Table 19. Global Stable Isotopically Labeled Compounds Sales Market Share by Region (2017-2022)
Table 20. Global Stable Isotopically Labeled Compounds Sales by Region (2023-2028) & (Tons)
Table 21. Global Stable Isotopically Labeled Compounds Sales Market Share by Region (2023-2028)
Table 22. Global Stable Isotopically Labeled Compounds Revenue by Region (2017-2022) & (US$ Million)
Table 23. Global Stable Isotopically Labeled Compounds Revenue Market Share by Region (2017-2022)
Table 24. Global Stable Isotopically Labeled Compounds Revenue by Region (2023-2028) & (US$ Million)
Table 25. Global Stable Isotopically Labeled Compounds Revenue Market Share by Region (2023-2028)
Table 26. Global Stable Isotopically Labeled Compounds Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 27. Global Stable Isotopically Labeled Compounds Capacity Market Share by Manufacturers (2017-2022)
Table 28. Global Stable Isotopically Labeled Compounds Sales by Manufacturers (2017-2022) & (Tons)
Table 29. Global Stable Isotopically Labeled Compounds Sales Market Share by Manufacturers (2017-2022)
Table 30. Global Stable Isotopically Labeled Compounds Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 31. Global Stable Isotopically Labeled Compounds Revenue Share by Manufacturers (2017-2022)
Table 32. Stable Isotopically Labeled Compounds Price by Manufacturers 2017-2022 (US$/Ton)
Table 33. Global Stable Isotopically Labeled Compounds Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Stable Isotopically Labeled Compounds by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stable Isotopically Labeled Compounds as of 2021)
Table 35. Stable Isotopically Labeled Compounds Manufacturing Base Distribution and Headquarters
Table 36. Manufacturers Stable Isotopically Labeled Compounds Product Offered
Table 37. Date of Manufacturers Enter into Stable Isotopically Labeled Compounds Market
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Stable Isotopically Labeled Compounds Sales by Type (2017-2022) & (Tons)
Table 40. Global Stable Isotopically Labeled Compounds Sales by Type (2023-2028) & (Tons)
Table 41. Global Stable Isotopically Labeled Compounds Sales Share by Type (2017-2022)
Table 42. Global Stable Isotopically Labeled Compounds Sales Share by Type (2023-2028)
Table 43. Global Stable Isotopically Labeled Compounds Revenue by Type (2017-2022) & (US$ Million)
Table 44. Global Stable Isotopically Labeled Compounds Revenue by Type (2023-2028) & (US$ Million)
Table 45. Global Stable Isotopically Labeled Compounds Revenue Share by Type (2017-2022)
Table 46. Global Stable Isotopically Labeled Compounds Revenue Share by Type (2023-2028)
Table 47. Stable Isotopically Labeled Compounds Price by Type (2017-2022) & (US$/Ton)
Table 48. Global Stable Isotopically Labeled Compounds Price Forecast by Type (2023-2028) & (US$/Ton)
Table 49. Global Stable Isotopically Labeled Compounds Sales by Application (2017-2022) & (Tons)
Table 50. Global Stable Isotopically Labeled Compounds Sales by Application (2023-2028) & (Tons)
Table 51. Global Stable Isotopically Labeled Compounds Sales Share by Application (2017-2022)
Table 52. Global Stable Isotopically Labeled Compounds Sales Share by Application (2023-2028)
Table 53. Global Stable Isotopically Labeled Compounds Revenue by Application (2017-2022) & (US$ Million)
Table 54. Global Stable Isotopically Labeled Compounds Revenue by Application (2023-2028) & (US$ Million)
Table 55. Global Stable Isotopically Labeled Compounds Revenue Share by Application (2017-2022)
Table 56. Global Stable Isotopically Labeled Compounds Revenue Share by Application (2023-2028)
Table 57. Stable Isotopically Labeled Compounds Price by Application (2017-2022) & (US$/Ton)
Table 58. Global Stable Isotopically Labeled Compounds Price Forecast by Application (2023-2028) & (US$/Ton)
Table 59. North America Stable Isotopically Labeled Compounds Sales by Type (2017-2022) & (Tons)
Table 60. North America Stable Isotopically Labeled Compounds Sales by Type (2023-2028) & (Tons)
Table 61. North America Stable Isotopically Labeled Compounds Revenue by Type (2017-2022) & (US$ Million)
Table 62. North America Stable Isotopically Labeled Compounds Revenue by Type (2023-2028) & (US$ Million)
Table 63. North America Stable Isotopically Labeled Compounds Sales by Application (2017-2022) & (Tons)
Table 64. North America Stable Isotopically Labeled Compounds Sales by Application (2023-2028) & (Tons)
Table 65. North America Stable Isotopically Labeled Compounds Revenue by Application (2017-2022) & (US$ Million)
Table 66. North America Stable Isotopically Labeled Compounds Revenue by Application (2023-2028) & (US$ Million)
Table 67. North America Stable Isotopically Labeled Compounds Sales by Country (2017-2022) & (Tons)
Table 68. North America Stable Isotopically Labeled Compounds Sales by Country (2023-2028) & (Tons)
Table 69. North America Stable Isotopically Labeled Compounds Revenue by Country (2017-2022) & (US$ Million)
Table 70. North America Stable Isotopically Labeled Compounds Revenue by Country (2023-2028) & (US$ Million)
Table 71. Europe Stable Isotopically Labeled Compounds Sales by Type (2017-2022) & (Tons)
Table 72. Europe Stable Isotopically Labeled Compounds Sales by Type (2023-2028) & (Tons)
Table 73. Europe Stable Isotopically Labeled Compounds Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Stable Isotopically Labeled Compounds Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Stable Isotopically Labeled Compounds Sales by Application (2017-2022) & (Tons)
Table 76. Europe Stable Isotopically Labeled Compounds Sales by Application (2023-2028) & (Tons)
Table 77. Europe Stable Isotopically Labeled Compounds Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Stable Isotopically Labeled Compounds Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Stable Isotopically Labeled Compounds Sales by Country (2017-2022) & (Tons)
Table 80. Europe Stable Isotopically Labeled Compounds Sales by Country (2023-2028) & (Tons)
Table 81. Europe Stable Isotopically Labeled Compounds Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Stable Isotopically Labeled Compounds Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Stable Isotopically Labeled Compounds Sales by Type (2017-2022) & (Tons)
Table 84. Asia Pacific Stable Isotopically Labeled Compounds Sales by Type (2023-2028) & (Tons)
Table 85. Asia Pacific Stable Isotopically Labeled Compounds Revenue by Type (2017-2022) & (US$ Million)
Table 86. Asia Pacific Stable Isotopically Labeled Compounds Revenue by Type (2023-2028) & (US$ Million)
Table 87. Asia Pacific Stable Isotopically Labeled Compounds Sales by Application (2017-2022) & (Tons)
Table 88. Asia Pacific Stable Isotopically Labeled Compounds Sales by Application (2023-2028) & (Tons)
Table 89. Asia Pacific Stable Isotopically Labeled Compounds Revenue by Application (2017-2022) & (US$ Million)
Table 90. Asia Pacific Stable Isotopically Labeled Compounds Revenue by Application (2023-2028) & (US$ Million)
Table 91. Asia Pacific Stable Isotopically Labeled Compounds Sales by Region (2017-2022) & (Tons)
Table 92. Asia Pacific Stable Isotopically Labeled Compounds Sales by Region (2023-2028) & (Tons)
Table 93. Asia Pacific Stable Isotopically Labeled Compounds Revenue by Region (2017-2022) & (US$ Million)
Table 94. Asia Pacific Stable Isotopically Labeled Compounds Revenue by Region (2023-2028) & (US$ Million)
Table 95. Latin America Stable Isotopically Labeled Compounds Sales by Type (2017-2022) & (Tons)
Table 96. Latin America Stable Isotopically Labeled Compounds Sales by Type (2023-2028) & (Tons)
Table 97. Latin America Stable Isotopically Labeled Compounds Revenue by Type (2017-2022) & (US$ Million)
Table 98. Latin America Stable Isotopically Labeled Compounds Revenue by Type (2023-2028) & (US$ Million)
Table 99. Latin America Stable Isotopically Labeled Compounds Sales by Application (2017-2022) & (Tons)
Table 100. Latin America Stable Isotopically Labeled Compounds Sales by Application (2023-2028) & (Tons)
Table 101. Latin America Stable Isotopically Labeled Compounds Revenue by Application (2017-2022) & (US$ Million)
Table 102. Latin America Stable Isotopically Labeled Compounds Revenue by Application (2023-2028) & (US$ Million)
Table 103. Latin America Stable Isotopically Labeled Compounds Sales by Country (2017-2022) & (Tons)
Table 104. Latin America Stable Isotopically Labeled Compounds Sales by Country (2023-2028) & (Tons)
Table 105. Latin America Stable Isotopically Labeled Compounds Revenue by Country (2017-2022) & (US$ Million)
Table 106. Latin America Stable Isotopically Labeled Compounds Revenue by Country (2023-2028) & (US$ Million)
Table 107. Middle East and Africa Stable Isotopically Labeled Compounds Sales by Type (2017-2022) & (Tons)
Table 108. Middle East and Africa Stable Isotopically Labeled Compounds Sales by Type (2023-2028) & (Tons)
Table 109. Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Type (2017-2022) & (US$ Million)
Table 110. Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Type (2023-2028) & (US$ Million)
Table 111. Middle East and Africa Stable Isotopically Labeled Compounds Sales by Application (2017-2022) & (Tons)
Table 112. Middle East and Africa Stable Isotopically Labeled Compounds Sales by Application (2023-2028) & (Tons)
Table 113. Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Application (2017-2022) & (US$ Million)
Table 114. Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Application (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Stable Isotopically Labeled Compounds Sales by Country (2017-2022) & (Tons)
Table 116. Middle East and Africa Stable Isotopically Labeled Compounds Sales by Country (2023-2028) & (Tons)
Table 117. Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Country (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Country (2023-2028) & (US$ Million)
Table 119. Rotem Industries Israel Corporation Information
Table 120. Rotem Industries Israel Description and Major Businesses
Table 121. Rotem Industries Israel Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 122. Rotem Industries Israel Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Rotem Industries Israel Recent Development
Table 124. Huayi Isotopes Corporation Information
Table 125. Huayi Isotopes Description and Major Businesses
Table 126. Huayi Isotopes Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 127. Huayi Isotopes Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Huayi Isotopes Recent Development
Table 129. ABX Corporation Information
Table 130. ABX Description and Major Businesses
Table 131. ABX Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 132. ABX Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. ABX Recent Development
Table 134. CIL Corporation Information
Table 135. CIL Description and Major Businesses
Table 136. CIL Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 137. CIL Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. CIL Recent Development
Table 139. Wosotop Corporation Information
Table 140. Wosotop Description and Major Businesses
Table 141. Wosotop Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 142. Wosotop Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Wosotop Recent Development
Table 144. Tayio Nippon Sanso Corporation Information
Table 145. Tayio Nippon Sanso Description and Major Businesses
Table 146. Tayio Nippon Sanso Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 147. Tayio Nippon Sanso Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Tayio Nippon Sanso Recent Development
Table 149. CMR Corporation Information
Table 150. CMR Description and Major Businesses
Table 151. CMR Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 152. CMR Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. CMR Recent Development
Table 154. Cambridge Isotope Laboratories Corporation Information
Table 155. Cambridge Isotope Laboratories Description and Major Businesses
Table 156. Cambridge Isotope Laboratories Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 157. Cambridge Isotope Laboratories Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Cambridge Isotope Laboratories Recent Development
Table 159. Merck KGaA Corporation Information
Table 160. Merck KGaA Description and Major Businesses
Table 161. Merck KGaA Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 162. Merck KGaA Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Merck KGaA Recent Development
Table 164. Urenco Limited Corporation Information
Table 165. Urenco Limited Description and Major Businesses
Table 166. Urenco Limited Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 167. Urenco Limited Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Urenco Limited Recent Development
Table 169. Isosciences Corporation Information
Table 170. Isosciences Description and Major Businesses
Table 171. Isosciences Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 172. Isosciences Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Isosciences Recent Development
Table 174. Medical Isotopes Corporation Information
Table 175. Medical Isotopes Description and Major Businesses
Table 176. Medical Isotopes Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 177. Medical Isotopes Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Medical Isotopes Recent Development
Table 179. Omicron Biochemicals Corporation Information
Table 180. Omicron Biochemicals Description and Major Businesses
Table 181. Omicron Biochemicals Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 182. Omicron Biochemicals Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Omicron Biochemicals Recent Development
Table 184. BWX Technologies Corporation Information
Table 185. BWX Technologies Description and Major Businesses
Table 186. BWX Technologies Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 187. BWX Technologies Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. BWX Technologies Recent Development
Table 189. Trace Sciences International Corporation Information
Table 190. Trace Sciences International Description and Major Businesses
Table 191. Trace Sciences International Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 192. Trace Sciences International Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Trace Sciences International Recent Development
Table 194. Alsachim Corporation Information
Table 195. Alsachim Description and Major Businesses
Table 196. Alsachim Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 197. Alsachim Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Alsachim Recent Development
Table 199. Perkinelmer Corporation Information
Table 200. Perkinelmer Description and Major Businesses
Table 201. Perkinelmer Stable Isotopically Labeled Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 202. Perkinelmer Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Perkinelmer Recent Development
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Stable Isotopically Labeled Compounds Distributors List
Table 207. Stable Isotopically Labeled Compounds Customers List
Table 208. Stable Isotopically Labeled Compounds Market Trends
Table 209. Stable Isotopically Labeled Compounds Market Drivers
Table 210. Stable Isotopically Labeled Compounds Market Challenges
Table 211. Stable Isotopically Labeled Compounds Market Restraints
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Stable Isotopically Labeled Compounds Product Picture
Figure 2. Global Stable Isotopically Labeled Compounds Market Share by Type in 2021 & 2028
Figure 3. Water-18O Product Picture
Figure 4. Oxygen-18O Product Picture
Figure 5. 13C Labelled Compounds Product Picture
Figure 6. 18F Labelled Compounds Product Picture
Figure 7. 11C Labelled Compounds Product Picture
Figure 8. D Labelled Compounds Product Picture
Figure 9. 2H Labelled Compounds Product Picture
Figure 10. 15N Labelled Compounds Product Picture
Figure 11. Others Product Picture
Figure 12. Global Stable Isotopically Labeled Compounds Market Share by Application in 2021 & 2028
Figure 13. Scientific Research
Figure 14. Clinical Diagnostics
Figure 15. Industrial
Figure 16. Others
Figure 17. Stable Isotopically Labeled Compounds Report Years Considered
Figure 18. Global Stable Isotopically Labeled Compounds Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 19. Global Stable Isotopically Labeled Compounds Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Stable Isotopically Labeled Compounds Production Market Share by Region (2017-2022)
Figure 21. Global Stable Isotopically Labeled Compounds Production Market Share by Region (2023-2028)
Figure 22. Stable Isotopically Labeled Compounds Production Growth Rate in North America (2017-2028) & (Tons)
Figure 23. Stable Isotopically Labeled Compounds Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 24. Stable Isotopically Labeled Compounds Production Growth Rate in China (2017-2028) & (Tons)
Figure 25. Stable Isotopically Labeled Compounds Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 26. Global Stable Isotopically Labeled Compounds Sales 2017-2028 (Tons)
Figure 27. Global Stable Isotopically Labeled Compounds Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 28. Global Stable Isotopically Labeled Compounds Revenue 2017-2028 (US$ Million)
Figure 29. Global Stable Isotopically Labeled Compounds Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 30. Global Stable Isotopically Labeled Compounds Sales Market Share by Region (2017-2022)
Figure 31. Global Stable Isotopically Labeled Compounds Sales Market Share by Region (2023-2028)
Figure 32. North America Stable Isotopically Labeled Compounds Sales YoY (2017-2028) & (Tons)
Figure 33. North America Stable Isotopically Labeled Compounds Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Europe Stable Isotopically Labeled Compounds Sales YoY (2017-2028) & (Tons)
Figure 35. Europe Stable Isotopically Labeled Compounds Revenue YoY (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Stable Isotopically Labeled Compounds Sales YoY (2017-2028) & (Tons)
Figure 37. Asia-Pacific Stable Isotopically Labeled Compounds Revenue YoY (2017-2028) & (US$ Million)
Figure 38. Latin America Stable Isotopically Labeled Compounds Sales YoY (2017-2028) & (Tons)
Figure 39. Latin America Stable Isotopically Labeled Compounds Revenue YoY (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Stable Isotopically Labeled Compounds Sales YoY (2017-2028) & (Tons)
Figure 41. Middle East & Africa Stable Isotopically Labeled Compounds Revenue YoY (2017-2028) & (US$ Million)
Figure 42. The Stable Isotopically Labeled Compounds Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 43. The Top 5 and 10 Largest Manufacturers of Stable Isotopically Labeled Compounds in the World: Market Share by Stable Isotopically Labeled Compounds Revenue in 2021
Figure 44. Stable Isotopically Labeled Compounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 45. Global Stable Isotopically Labeled Compounds Sales Market Share by Type (2017-2028)
Figure 46. Global Stable Isotopically Labeled Compounds Revenue Market Share by Type (2017-2028)
Figure 47. Global Stable Isotopically Labeled Compounds Sales Market Share by Application (2017-2028)
Figure 48. Global Stable Isotopically Labeled Compounds Revenue Market Share by Application (2017-2028)
Figure 49. North America Stable Isotopically Labeled Compounds Sales Market Share by Type (2017-2028)
Figure 50. North America Stable Isotopically Labeled Compounds Revenue Market Share by Type (2017-2028)
Figure 51. North America Stable Isotopically Labeled Compounds Sales Market Share by Application (2017-2028)
Figure 52. North America Stable Isotopically Labeled Compounds Revenue Market Share by Application (2017-2028)
Figure 53. North America Stable Isotopically Labeled Compounds Sales Share by Country (2017-2028)
Figure 54. North America Stable Isotopically Labeled Compounds Revenue Share by Country (2017-2028)
Figure 55. United States Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 56. Canada Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 57. Europe Stable Isotopically Labeled Compounds Sales Market Share by Type (2017-2028)
Figure 58. Europe Stable Isotopically Labeled Compounds Revenue Market Share by Type (2017-2028)
Figure 59. Europe Stable Isotopically Labeled Compounds Sales Market Share by Application (2017-2028)
Figure 60. Europe Stable Isotopically Labeled Compounds Revenue Market Share by Application (2017-2028)
Figure 61. Europe Stable Isotopically Labeled Compounds Sales Share by Country (2017-2028)
Figure 62. Europe Stable Isotopically Labeled Compounds Revenue Share by Country (2017-2028)
Figure 63. Germany Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 64. France Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 65. U.K. Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 66. Italy Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 67. Russia Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 68. Asia Pacific Stable Isotopically Labeled Compounds Sales Market Share by Type (2017-2028)
Figure 69. Asia Pacific Stable Isotopically Labeled Compounds Revenue Market Share by Type (2017-2028)
Figure 70. Asia Pacific Stable Isotopically Labeled Compounds Sales Market Share by Application (2017-2028)
Figure 71. Asia Pacific Stable Isotopically Labeled Compounds Revenue Market Share by Application (2017-2028)
Figure 72. Asia Pacific Stable Isotopically Labeled Compounds Sales Share by Region (2017-2028)
Figure 73. Asia Pacific Stable Isotopically Labeled Compounds Revenue Share by Region (2017-2028)
Figure 74. China Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 75. Japan Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 76. South Korea Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 77. India Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 78. Australia Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 79. China Taiwan Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 80. Indonesia Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 81. Thailand Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 82. Malaysia Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 83. Latin America Stable Isotopically Labeled Compounds Sales Market Share by Type (2017-2028)
Figure 84. Latin America Stable Isotopically Labeled Compounds Revenue Market Share by Type (2017-2028)
Figure 85. Latin America Stable Isotopically Labeled Compounds Sales Market Share by Application (2017-2028)
Figure 86. Latin America Stable Isotopically Labeled Compounds Revenue Market Share by Application (2017-2028)
Figure 87. Latin America Stable Isotopically Labeled Compounds Sales Share by Country (2017-2028)
Figure 88. Latin America Stable Isotopically Labeled Compounds Revenue Share by Country (2017-2028)
Figure 89. Mexico Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 90. Brazil Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 91. Argentina Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 92. Middle East and Africa Stable Isotopically Labeled Compounds Sales Market Share by Type (2017-2028)
Figure 93. Middle East and Africa Stable Isotopically Labeled Compounds Revenue Market Share by Type (2017-2028)
Figure 94. Middle East and Africa Stable Isotopically Labeled Compounds Sales Market Share by Application (2017-2028)
Figure 95. Middle East and Africa Stable Isotopically Labeled Compounds Revenue Market Share by Application (2017-2028)
Figure 96. Middle East and Africa Stable Isotopically Labeled Compounds Sales Share by Country (2017-2028)
Figure 97. Middle East and Africa Stable Isotopically Labeled Compounds Revenue Share by Country (2017-2028)
Figure 98. Turkey Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 99. Saudi Arabia Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 100. UAE Stable Isotopically Labeled Compounds Revenue (2017-2028) & (US$ Million)
Figure 101. Stable Isotopically Labeled Compounds Value Chain
Figure 102. Stable Isotopically Labeled Compounds Production Process
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed

---